Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines

Ning,Xianbin; Zhao,Changfu; Pang,Jinfeng; Ding,Zhaoyi; Wang,Yubo; Xu,Kan; Chen,Hao; Li,Bingwei; Luo,Qi

doi:10.3892/etm.2015.2479

Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines

Authors:
- Xianbin Ning
- Changfu Zhao
- Jinfeng Pang
- Zhaoyi Ding
- Yubo Wang
- Kan Xu
- Hao Chen
- Bingwei Li
- Qi Luo
View Affiliations

Affiliations: Department of Neurosurgery, The Affiliated Hospital of Beihua University, Jilin City, Jilin 132011, P.R. China, Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: May 7, 2015 https://doi.org/10.3892/etm.2015.2479
Pages: 316-322

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the feasibility of the non-adhesive temperature-sensitive liquid embolic material, chitosan/β‑glycerophosphate (C/GP), in embolizing the basicranial rete mirabile (REM) in a swine model of cerebral arteriovenous malformation (cAVM). A total of 24 domestic swines were used as the experimental animals, among which 12 pigs underwent direct embolization of one side of the REM, while the other 12 pigs underwent embolization of the bilateral REM following anastomosis of the carotid artery and jugular vein. A super‑selective microcatheter was introduced into the REM during the embolization procedure, and the C/GP hydrogel was injected until an image of the REM disappeared in the angiography examination. Further angiography examinations were performed after 2 and 6 weeks, and histological examination of the REM was performed after 6 weeks. Of the 24 domestic swines, 23 cases underwent successful thrombosis. Convulsions occurred in one case and that pig died during the embolization procedure. Following embolization, the angiography observations revealed that the embolized REM was no longer able to be developed, and adhesion of the microcatheter tip with the embolic agent did not occur. In addition, no apparent revascularization was observed in the angiography examinations performed at weeks 2 and 6. Therefore, the current preliminary study indicated that use of the non‑adhesive temperature‑sensitive embolic material was feasible for the embolization of cAVM; thus, C/GP may be used as an ideal embolic material for the treatment of cAVM.

View Figures

View References

1	Aoun SG, Bendok BR and Batjer HH: Acute management of ruptured arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 23:87–103. 2012. View Article : Google Scholar : PubMed/NCBI
2	Gross BA and Du R: Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 118:437–443. 2013. View Article : Google Scholar : PubMed/NCBI
3	Jabbour MN, Elder JB, Samuelson CG, et al: Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells. Neurosurgery. 64:139–148. 2009. View Article : Google Scholar : PubMed/NCBI
4	Chenite A, Chaput C, Wang D, et al: Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 21:2155–2161. 2000. View Article : Google Scholar : PubMed/NCBI
5	National Research Council (USA) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the Care and Use of Laboratory Animals. 8th. National Academies Press; Washington D.C., USA: 2011
6	Lee DH, Wriedt CH, Kaufmann JC, Pelz DM, Fox AJ and Vinuela F: Evaluation of three embolic agents in pig rete. AJNR Am J Neuroradiol. 10:773–776. 1989.PubMed/NCBI
7	Massoud TF, Vinters HV, Chao KH, Viñuela F and Jahan R: Histopathologic characteristics of a chronic arteriovenous malformation in a swine model: preliminary study. AJNR Am J Neuroradiol. 21:1268–1276. 2000.PubMed/NCBI
8	da Costa L, Wallace MC, Ter Brugge KG, OKelly C, Willinsky RA and Tymianski M: The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 40:100–105. 2009. View Article : Google Scholar : PubMed/NCBI
9	Choi JH, Mast H, Hartmann A, Marshall RS, Pile-Spellman J, Mohr JP and Stapf C: Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation. J Neurol Sci. 287:126–130. 2009. View Article : Google Scholar : PubMed/NCBI
10	Gabriel RA, Kim H, Sidney S, et al: Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 41:21–26. 2010. View Article : Google Scholar : PubMed/NCBI
11	Kim H, Pawlikowska L, Chen Y, Su H, Yang GY and Young WL: Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke. 40:(Suppl). S95–S97. 2009. View Article : Google Scholar : PubMed/NCBI
12	Colombo F, Cavedon C, Casentini L, Francescon P, Causin F and Pinna V: Early results of CyberKnife radiosurgery for arteriovenous malformations. J Neurosurg. 111:807–819. 2009. View Article : Google Scholar : PubMed/NCBI
13	Natarajan SK, Ghodke B, Britz GW, Born DE and Sekhar LN: Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 62:1213–1226. 2008. View Article : Google Scholar : PubMed/NCBI
14	Sorimachi T, Koike T, Takeuchi S, et al: Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: Angiographic reappearance and complications. AJNR Am J Neuroradiol. 20:1323–1328. 1999.PubMed/NCBI
15	Lieber BB, Wakhloo AK, Siekmann R and Gounis MJ: Acute and chronic swine rete arteriovenous malformation models: effect of ethiodol and glacial acetic acid on penetration, dispersion and injection force of N-butyl 2-cyanoacrylate. AJNR Am J Neuroradiol. 26:1707–1714. 2005.PubMed/NCBI
16	Natarajan SK, Born D, Ghodke B, Britz GW and Sekhar LN: Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation. J Neurosurg. 111:105–113. 2009. View Article : Google Scholar : PubMed/NCBI
17	Starke RM, Komotar RJ, Otten ML, et al: Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications and predictors of neurologic deficits. Stroke. 40:2783–2790. 2009. View Article : Google Scholar : PubMed/NCBI
18	Strozyk D, Nogueira RG and Lavine SD: Endovascular treatment of intracranial arteriovenous malformation. Neurosurg Clin N Am. 20:399–418. 2009. View Article : Google Scholar : PubMed/NCBI
19	Dudeck O, Jordan O, Hoffmann KT, et al: Intrinsically radiopaque iodine-containing polyvinyl alcohol as a liquid embolic agent: evaluation in experimental wide-necked aneurysms. J Neurosurg. 104:290–297. 2006. View Article : Google Scholar : PubMed/NCBI
20	Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M and Wanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroadiol. 30:99–106. 2009. View Article : Google Scholar
21	Murayama Y, Viñuela F, Ulhoa A, et al: Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurg. 1998.43:1164–1175. View Article : Google Scholar
22	Chenite A, Chaput C, Wang D, et al: Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 21:2155–2161. 2000. View Article : Google Scholar : PubMed/NCBI
23	Casettari L, Cespi M, Palmieri GF and Bonacucina G: Characterization of the interaction between chitosan and inorganic sodium phosphates by means of rheological and optical microscopy studies. Carbohydr Polym. 91:597–602. 2013. View Article : Google Scholar : PubMed/NCBI
24	Hsiao MH, Larsson M, Larsson A, Evenbratt H, Chen YY, Chen YY and Liu DM: Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide. J Control Release. 161:942–948. 2012. View Article : Google Scholar : PubMed/NCBI
25	Wang Y, Xu N, Luo Q, et al: In vivo assessment of chitosan/β-glycerophosphate as a new liquid embolic agent. Interv Neuroradiol. 17:87–92. 2011.PubMed/NCBI
26	Lajud SA, Han Z, Chi FL, et al: A regulated delivery system for inner ear drug application. J Control Release. 166:268–276. 2013. View Article : Google Scholar : PubMed/NCBI
27	Khodaverdi E, Tafaghodi M, Ganji F, Abnoos K and Naghizadeh H: In vitro insulin release from thermosensitive chitosan hydrogel. AAPS PharmSciTech. 13:460–466. 2012. View Article : Google Scholar : PubMed/NCBI
28	Liu Z, Wang H, Wang Y, et al: The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 33:3093–3106. 2012. View Article : Google Scholar : PubMed/NCBI
29	Alinaghi A, Rouini MR, Johari Daha F and Moghimi HR: Hydrogel-embeded vesicles, as a novel approach for prolonged release and delivery of liposome, in vitro and in vivo. J Liposome Res. 23:235–243. 2013. View Article : Google Scholar : PubMed/NCBI